Pliant Therapeutics halted new enrollment in its BEACON-IPF trial after a safety board review. A separate study showed ...

Positron Co. (OTCMKTS:POSC – Get Free Report) shares fell 6.2% during mid-day trading on Friday . The company traded as low as $1.78 and last traded at $1.81. 34,998 shares traded hands during trading ...

Scanners IndustryThe global positron emission tomography (PET) scanners market is set to experience significant growth, with an estimated valuation of USD 1.3 billion in 2023 and a projected increase ...

Radiopharm Theranostic (RADX)s announced the publication of a novel imaging approach demonstrating proof-of-concept for the use of RAD 101 for ...

Because it can only be diagnosed with an autopsy, the neurodegenerative disease is difficult to pin in cases of professional ...

Successful detection of brain metastases using RAD 101 (18F-Pivalate) in a novel multiparametric imaging methodology ...

POSC), a leading molecular imaging medical device company specializing in PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems and clinical services, is pleased to ...

With the aim to add a “revenue generating CDMO arm,” Lantheus Holdings has bought New Jersey-based radiopharmaceutical ...

Patients with predominantly cranial vs isolated extracranial GCA phenotypes present with different patterns of arterial involvement on 18F-FDG PET-CT scans.